Inspira Technologies Oxy BHN Ltd - Asset Resilience Ratio
Inspira Technologies Oxy BHN Ltd (IINN) has an Asset Resilience Ratio of 8.28% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2022–2024)
This chart shows how Inspira Technologies Oxy BHN Ltd's Asset Resilience Ratio has changed over time. Check strategic asset allocation of Inspira Technologies Oxy BHN Ltd to assess the company's strategic physical and investment asset allocation.
Liquid Assets Composition Over Time
This chart breaks down Inspira Technologies Oxy BHN Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Inspira Technologies Oxy BHN Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $668.00K | 8.28% |
| Total Liquid Assets | $668.00K | 8.28% |
Asset Resilience Insights
- Limited Liquidity: Inspira Technologies Oxy BHN Ltd maintains only 8.28% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Inspira Technologies Oxy BHN Ltd Industry Peers by Asset Resilience Ratio
Compare Inspira Technologies Oxy BHN Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Bio-Rad Laboratories Inc
NYSE:BIO |
Medical Devices | 10.80% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 9.96% |
|
Affluent Medical SAS
PA:AFME |
Medical Devices | 0.03% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Anteris Technologies Global Corp
AU:AVR |
Medical Devices | 33.27% |
|
Imricor Medical Systems Inc
AU:IMR |
Medical Devices | 46.50% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
Annual Asset Resilience Ratio for Inspira Technologies Oxy BHN Ltd (2022–2024)
The table below shows the annual Asset Resilience Ratio data for Inspira Technologies Oxy BHN Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 8.28% | $668.00K | $8.07 Million | -16.64pp |
| 2023-12-31 | 24.92% | $2.32 Million | $9.31 Million | -19.55pp |
| 2022-12-31 | 44.47% | $7.12 Million | $16.01 Million | -- |
About Inspira Technologies Oxy BHN Ltd
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as In… Read more